PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-23.77%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-392.47%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
44.06%
Positive EBIT growth while RUN is negative. John Neff might see a substantial edge in operational management.
-116.79%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
43.28%
Positive net income growth while RUN is negative. John Neff might see a big relative performance advantage.
43.75%
Positive EPS growth while RUN is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
43.75%
Positive diluted EPS growth while RUN is negative. John Neff might view this as a strong relative advantage in controlling dilution.
0.41%
Share reduction more than 1.5x RUN's 1.45%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
0.41%
Diluted share reduction more than 1.5x RUN's 1.45%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
No Data
No Data available this quarter, please select a different quarter.
-466.37%
Negative OCF growth while RUN is at 152.54%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-118.25%
Negative FCF growth while RUN is at 26.59%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-3.74%
Negative 10Y revenue/share CAGR while RUN stands at 345.18%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-56.64%
Negative 5Y CAGR while RUN stands at 345.18%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-12.41%
Negative 3Y CAGR while RUN stands at 75.12%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-65.78%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-354.59%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
60.99%
3Y OCF/share CAGR at 50-75% of RUN's 113.11%. Martin Whitman would suspect weaker recent execution or product competitiveness.
-438.19%
Negative 10Y net income/share CAGR while RUN is at 17.70%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-218.94%
Negative 5Y net income/share CAGR while RUN is 17.70%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-1.70%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
-115.11%
Negative equity/share CAGR over 10 years while RUN stands at 93.56%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-121.56%
Negative 5Y equity/share growth while RUN is at 93.56%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-120.43%
Negative 3Y equity/share growth while RUN is at 45.28%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-10.00%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
8.52%
We show growth while RUN is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
-1.91%
Negative asset growth while RUN invests at 4.00%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-47.14%
We have a declining book value while RUN shows 0.71%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
7.93%
Debt growth far above RUN's 2.92%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
-3.72%
Our R&D shrinks while RUN invests at 3.44%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
16.75%
We expand SG&A while RUN cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.